Pulse Biosciences, Inc. (PLSE) — Financial statements
Income statement, balance sheet, and cash flow for Pulse Biosciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.35 | 0.00 | 0.00↓100.0% | 0.70↓50.6% | 1 | |
| Cost of Revenue | 2 | 0.00↓100.0% | 1↓89.9% | 12↑506.9% | 2 | |
| Gross Profit | -1 | 0.00↑100.0% | -1↑89.3% | -11↓1944.4% | -0.55 | |
| Operating Expenses | ||||||
| R&D Expenses | 45↑38.3% | 32↑16.3% | 28↑33.4% | 21↓27.2% | 29 | |
| General & Administrative Expenses | 0.00↓100.0% | 24↑51.6% | 16↑13.1% | 14↓26.8% | 19 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00↓100.0% | 12↓18.5% | 15 | |
| SG&A Expenses | 32↑33.9% | 24↑51.6% | 16↓39.3% | 26↓23.2% | 34 | |
| Other Expenses | -1 | 0.00↑100.0% | -1 | 0.00 | 0.00 | |
| Operating Expenses | 76↑34.5% | 56↑32.8% | 42↓9.5% | 47↓25.1% | 62 | |
| Total Costs & Expenses | 77↑37.4% | 56↑29.1% | 44↓25.8% | 59↓8.8% | 64 | |
| Operating Results | ||||||
| Operating Income | -77↓36.8% | -56↓29.1% | -44↑24.9% | -58↑7.9% | -63 | |
| Depreciation & Amortization | 1↓9.1% | 1↓2.4% | 1↓10.9% | 1↑18.2% | 1 | |
| EBITDA | -72↓30.2% | -55↓30.0% | -42↑25.3% | -57↑8.4% | -62 | |
| EBIT | -73↓29.4% | -56↓29.1% | -44↑24.9% | -58↑7.9% | -63 | |
| Interest & Other Income | ||||||
| Net Interest Income | 4↑57.6% | 3↑95.9% | 1 | 0.00 | 0.00 | |
| Interest Income | 4↑57.6% | 3↑8.4% | 2 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 1 | 0.00 | 0.00 | |
| Non-Operating Income | -4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 4↑55.6% | 3↑95.9% | 1↑404.5% | -0.45↑30.7% | -0.65 | |
| Income Before Tax | -73↓35.8% | -54↓26.9% | -42↑27.9% | -59↑8.1% | -64 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -73↓35.8% | -54↓26.9% | -42↑27.9% | -59↑8.1% | -64 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -73↓35.8% | -54↓26.9% | -42↑27.9% | -59↑8.1% | -64 | |
| Bottom-Line Net Income | -73↓35.8% | -54↓26.9% | -42↑27.9% | -59↑8.1% | -64 | |
| EPS (Basic) | -1.08↓17.4% | -0.92↓4.5% | -0.88↑48.8% | -1.72↑24.6% | -2.28 | |
| EPS (Diluted) | -1.08↓17.4% | -0.92↓4.5% | -0.88↑48.8% | -1.72↑24.6% | -2.28 | |
| Weighted Average Shares | 67↑15.4% | 58↑21.6% | 48↑41.6% | 34↑21.4% | 28 | |
| Weighted Average Diluted Shares | 67↑15.4% | 58↑21.6% | 48↑41.6% | 34↑21.4% | 28 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.